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DObjective: Recent advancements in total aortic arch replacement achieved by our approach were presented.
Methods: From January 2002 to December 2010, 321 consecutive patients (mean age 69.8  13.3 years) un-
derwent total arch replacement through a median sternotomy at our institute. Aortic dissection was present in
94 (28.3%) patients and shaggy aorta in 36 (11.2%), with emergency/urgent surgery required in 106
(33.0%). Our current approach included the following: (1) meticulous selection of arterial cannulation site
and type of arterial cannula; (2) antegrade selective cerebral perfusion; (3) maintenance of minimal tympanic
temperature between 20C and 23C; (4) early rewarming just after distal anastomosis; (5) after 2004, bolus in-
jection of 100 mg of sivelestat sodium hydrate into the pump circuit at the initiation of cardiopulmonary bypass;
(6) after 2006, maintaining fluid balance below 1000 mL during cardiopulmonary bypass.
Results: Overall hospital mortality was 4.4% (14/321) and was 1.9% (4/215) in elective cases. Permanent neu-
rologic deficit occurred in 4.4% (14/321) of patients and in 2.8% (6/215) of elective cases. Prolonged ventilation
was necessary in 53 (16.5%), with a significant reduction after 2006 (22.8% vs 12.6%; P ¼ .02). Multivariate
analysis demonstrated that risk factors for hospital mortality were octogenarian (odds ratio, 4.32; P¼ .03), brain
malperfusion (odds ratio, 21.2; P¼ .001) and cardiopulmonary bypass time (odds ratio, 1.01; P¼ .04). Survival
at 3 and 5 years after surgery was 82.4%  2.5% and 78.5%  3.1%, respectively.
Conclusions: Our current approach for total aortic arch replacement was associated with low hospital mortality
and morbidities and with favorable long-term outcome. (J Thorac Cardiovasc Surg 2012;144:139-45)Surgical techniques, perioperative care, and sealing grafts in
the field of aortic arch surgery have improved dramatically
over the past decade. Consequently, recent literature has de-
scribed improved outcomes in hospital mortality, with rates
of 5% or lower cited,1-3 whereas in the past figures in the
range of 10% were reported. It becomes imperative to
devise not only surgical techniques, but also preoperative
accurate imaging for aortic disease, and to monitor brain
perfusion, fluid balance during cardiopulmonary bypass
(CPB), and pharmacologic interventions for pulmonary
protection, which may lead to further improvement in
short- and long-tem outcomes in the treatment of aortic
arch disease.
The purpose of this retrospective study is to describe our
surgical approach for total aortic arch replacement (TAR)
and the satisfactory outcomes experienced at our institute.
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The Journal of Thoracic and CaPatient Profiles (Table 1)
From January 2002 to December 2010, 321 consecutive patients with
amean age of 69.8 13.3 yearswho underwent TAR through amedian ster-
notomy were retrospectively investigated. There were 66 (20.6%) octoge-
narians in the series. The type of aortic disease was aortic dissection in 94
(28.3%) including acute type A dissection in 61 (19.0%) and Marfan syn-
drome in 11 (3.4%). ‘‘Shaggy aorta’’ in the aortic arch was observed in 36
(11.2%). ‘‘Shaggy aorta’’ was defined as very extensive atheromatous dis-
easewith diffuse ulcers associatedwith soft, loosely held debris and a paucity
of actual thrombus; the term was advocated by Hollier and associates.4 Ac-
cordingly,when fragile and spiculatedatheromamore than5mmin thickness
was confirmed by both computed tomography and visual inspection in the
aortic arch except the aneurysm itself, the arch pathologic condition was de-
fined as shaggy aorta in the current study. Surgerywas performedon an emer-
gency/urgent basis in 106 (33.0%) patients. Other conditions included
a history of cerebral infarction in 32 (10.0%) patients, 72 (22.4%) with cor-
onary artery disease, 23 (7.2%) with chronic obstructive pulmonary disease,
and 25 (7.8%) with chronic kidney disease (creatinine  2.0 mg/dL).Current Surgical Approach
Our current approach since 2002 has been (1) meticulous selection of
arterial cannulation site and type of arterial cannula; (2) antegrade selective
cerebral perfusion (SCP) for cerebral protection; (3) whole body hypother-
mia with minimal tympanic temperatures between 20C and 23C, and
minimal rectal temperatures below 30C; (4) early rewarming after distal
anastomosis with antegrade SCP flow adjustment while monitoring brain
oxygenation by near-infrared spectroscopy (NIRS); (5) after 2004, bolus
injection of 100 mg of sivelestat sodium hydrate (ONO-5046) into the
pump circuit at the initiation of CPB5; and (6) after 2006, maintaining strict
fluid balance below 1000 mL by the extracorporeal ultrafiltration method
during CPB, with the expectation of more rapid pulmonary functional re-
covery. This overall approach has been applied for all cases since 2006.
Patients were placed in the supine position and the diodes of NIRS were
attached on the foreheads bilaterally. For NIRS we used INVOS 5100C
(Somanetics, Troy, Mich), which provides continuous regional cerebralrdiovascular Surgery c Volume 144, Number 1 139
Abbreviations and Acronyms
CA ¼ circulatory arrest
CPB ¼ cardiopulmonary bypass
NIRS ¼ near-infrared spectroscopy
OR ¼ odds ratio
PND ¼ permanent neurologic deficit
rSO2 ¼ regional cerebral oxygen saturation
SCP ¼ selective cerebral perfusion
TAR ¼ total aortic arch replacement
TND ¼ transient neurologic deficit
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Doxygen saturation (rSO2). The rSO2 readings are expressed as an index,
measuring differences from an unknown baseline.
Figure 1, A to H, shows a diagrammatic representation of the TAR pro-
cedure. CPB was established with bicaval drainage and the ascending aor-
tic perfusion in the majority of cases (n ¼ 244, 76.0%, Table 1, Figure 1,
B). The left side of the ventricle was vented through the right upper pulmo-
nary vein. Femoral artery cannulation was applied (n ¼ 54, 16.8%, Table
1), particularly in patients with aortic dissection. The selection of aortic
cannulas depended on the aortic disease, with the site being determined
by the findings of a preoperative computed tomographic and intraoperative
epiaortic echographic scan. If the ascending aorta/aortic arch was highly
diseased, a 24F Dispersion arterial cannula (Duraflo II; Edwards Lifescien-
ces LLC, Irvine, Calif) was inserted near the aortic root with perfusion to-
ward the aortic valve (n ¼ 46, 14.3%). All patients received 100 mg of
betamethasone sodium phosphate, and, after 2004, 100 mg of sivelestat so-
dium hydrate was added to the pump circuit at the initiation of CPB. After
the tympanic temperature had dropped to 20C to 23C with rectal temper-
ature below 30C, the aortic arch aneurysm was opened (Figure 1, C) and
antegrade SCP initiated. A 14F or 16F balloon-tipped cannula was inserted
from inside the aorta into the brachiocephalic artery, and 12F cannulas
were positioned in the left common carotid and left subclavian arteries.
Avoiding cerebral embolism was particularly important in SCP cannula-
tion. If the ostia of the arch vessels were severely atherosclerotic, arterio-
tomy of the arch vessels was extended from the diseased ostium to
a relatively clear distal part and then cannulas were placed in position under
direct vision. Antegrade SCP flow was maintained at 10 to 12 mL $ kg1 $
min1 using an independent roller pump, and balloon tip pressure was
maintained between 30 and 40 mm Hg. The distal aortic arch or the de-
scending aorta was transected from inside the aorta to avoid injury to the
recurrent nerve during circulatory arrest (CA) of the lower part of the
body (Figure 1, D). A sealed quadrifurcated Dacron graft or Triplex vascu-
lar graft (Terumo Corporation, Tokyo, Japan) was used. The open distal
aortic anastomosis was performed using a 4-0 polypropylene suture with
external Teflon felt reinforcement (Figure 1, E). An elephant trunk instal-
lation technique into the descending aorta was used for patients with acute
type A dissection. After completion of the distal anastomosis, the lower
body circulation was reinstituted through a branch graft and the tym-
panic/rectal temperature was rewarmed to 33C (Figure 1, F) and main-
tained at this level during the following procedures. Coincident with
rewarming, antegrade SCP flowwas gradually increased while maintaining
the baseline values of rSO2. However, antegrade SCP flow was limited be-
low 1200 mL/min to prevent brain edema. The proximal anastomosis was
then accomplished, followed by coronary reperfusion (Figure 1, G). Aortic
arch vessels were reconstructed with a 5-0 polypropylene suture. If patients
also had carotid artery or intracranial artery stenosis/occlusion, reconstruc-
tion was performed before rewarming. After 2006, fluid balance during
CPB was strictly controlled and kept below 1000 mL by the extracorporeal
ultrafiltration method (CAPIOX hemoconcentrator HC11, Terumo140 The Journal of Thoracic and Cardiovascular SurgCardiovascular Systems, Division of Terumo Corporation, Tokyo, Japan).
Other concurrent procedures are shown in Table 1.
Definition of Neurologic Deficits
‘‘Permanent neurologic dysfunction’’ was defined as the presence of
deficits that persisted at discharge and were caused by the intraoperative
procedure. ‘‘Transient dysfunction’’ was defined as transient loss of orien-
tation, slurred language, agitation, or poor response to commands. Neuro-
logic dysfunction caused by preoperative brain malperfusion associated
with acute type A dissection, deep shock status, and postoperative atrial fi-
brillation was excluded from this category.
Statistical Analysis
Data were processed using Stat View J-5.0 software (SAS Institute, Inc,
Cary, NC). Continuous values are expressed as the mean  standard devia-
tion. Data were analyzed by the c2 test for categorical variables. Stepwise
logistic regression analysiswas performed to identify the risk factors for hos-
pitalmortality, permanent neurologic deficit (PND), and transient neurologic
deficit (TND). Clinically relevant variables with P<.05 on univariate anal-
ysis were incorporated into the multivariate models. Survival and freedom
from aorta-related death were assessed by theKaplan-Meier method. Differ-
ences were considered statistically significant at P<.05.
RESULTS
Average CPB time, myocardial ischemic time, lower
body CA time, SCP time, andminimum tympanic and rectal
temperatures were 190.3  70.4 minutes, 91.3  51.4 min-
utes, 42.4  27.8 minutes, 97.3  31.4 minutes, 21.4C 
1.7C, and 25.7C 2.3C, respectively. Fluid balance dur-
ing CPBwas 938.2 1541.7 mL, but after 2006 the balance
was strictly controlled below 1000mL and values decreased
significantly from 1311.0  1463.8 mL before 2006 to
712.5  1551.6 mL (P ¼ .001) afterward.
Overall hospital mortality was 4.4% (14/320) and in
elective cases, 1.9% (4/215). Figure 2 provides annual fig-
ures for number of cases and hospital mortality. The cause
of death in all cases was as follows: central nervous system
in 5 patients (4 with preoperative brain malperfusion and 1
with preoperative deep shock), sepsis in 3, gastrointestinal
tract necrosis in 3, pulmonary related in 2, and hemorrhage
in 1. The cause of death in elective cases was gastrointesti-
nal tract necrosis in 2, sepsis in 1, and pulmonary related in
1. Table 2 shows the univariate and multivariate analysis for
in-hospital mortality. Multivariate analysis demonstrated
that risk factors for hospital mortality were octogenarian
(odds ratio [OR], 4.32; P ¼ .03), brain malperfusion (OR,
21.2; P ¼ .001), and CPB time (OR, 1.01; P ¼ .04).
A PND occurred in 14 (4.4%) patients after surgery and
in 6 (2.8%) patients operated on electively. An additional 5
patients had a neurologic deficit preoperatively, caused by
brainmalperfusion in 4 and by deep shock status in 1, result-
ing from left main trunk malperfusion associated with acute
type A aortic dissection. Two patients had stroke secondary
to postoperative atrial fibrillation. Table 3 shows the univar-
iate analysis for PND. Univariate analysis failed to identify
a risk factor for PND. ATND occurred in 21 (6.5%) patients
after surgery and in 19 (8.8%) patients operated onery c July 2012
TABLE 1. Patient profiles
Variables No. %
No. of patients 321
Age (y), mean  SD 69.8  13.3
Octogenarian 66 20.6
Male gender 234 72.9
Aortic disease
Dissection 94 28.3
Acute type A dissection 61 19.0
Brain malperfusion 8 2.5
Nondissection 227 70.7
Shaggy aorta 36 11.2
Marfan syndrome 11 3.4
Emergency/urgent 106 33.0
Rupture 26 8.1
Shock 9 2.8
Diabetes mellitus 37 11.5
Old cerebral infarction 32 10.0
Coronary artery disease 72 22.4
Left ventricular EF (40%) 11 3.4
Chronic obstructive pulmonary disease 23 7.2
Chronic kidney disease (Cr  2.0) 25 7.8
EuroSCORE 8.2  2.6
Concurrent procedure 122 38.0
Coronary artery bypass grafting 72 22.4
Aortic root replacement (valve-sparing) 12 3.7
Aortic root replacement (Bentall) 4 1.2
Aortic valve replacement 5 1.6
Mitral valve repair 3 0.9
Maze procedure 8 2.5
Abdominal aortic replacement 4 1.2
Cannulation sites/type for CPB
Ascending aorta/arch 244 76.0
Femoral artery 54 16.8
Axillary artery 3 0.9
Femoral arteryþaxillary artery 8 2.5
Ascending aortaþ femoral artery 10 3.1
24F Dispersion cannula 138 43.0
SD, Standard deviation; EF, ejection fraction; Cr, creatinine; CPB, cardiopulmonary
bypass.
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Delectively. Table 4 shows the univariate and multivariate
analysis for TND. Multivariate analysis demonstrated that
risk factors for TND were the aortic pathologic condition
of shaggy aorta (OR, 3.73;P¼ .018) and low left ventricular
ejection fraction (40%) (OR, 4.90; P ¼ .05).
Additional postoperative complications are shown in
Table 5. Mean mechanical ventilation time was 26.5 
46.4 hours. As for respiratory complications, 53 (16.5%)
patients required prolonged mechanical ventilation (48
hours). The incidence was 22.8% before and 12.6% after
2006 with a significant difference (P ¼ .02).
Follow-up was completed in 94.1% of patients, and the
mean follow-up period was 2.3 2.2 years. Figure 3 shows
overall long-term survival assessed by the Kaplan-Meier
method. Survival at 3 and 5 years after surgery was
82.4%  2.5% and 78.5%  3.1%, respectively.The Journal of Thoracic and CaFigure 4 shows freedom from aorta-related death assessed
by the Kaplan-Meier method. There were 4 patients who
died of aorta-related events during follow-up. Causes of
death were rupture of the penetrating atherosclerotic ulcer
in the descending aorta 1 year after TAR, rupture of thora-
coabdominal aortic aneurysm 3 years after TAR, sudden
death with hemoptysis, which presumably was caused by
aortopulmonary fistula, and sudden death of unknown rea-
son 4 months after TAR. The freedom from aorta-related
death at 3 and 5 years after surgery was 97.9%  1.1%
and 97.9%  1.1%, respectively.
DISCUSSION
The major findings of this study were that a standardized
approach for TAR since 2002 at our institute has resulted in
a low hospital mortality andmorbidity with a favorable long-
term survival and freedom from aorta-related death. Details
are spelled out in the ‘‘Current Surgical Approach’’ section.
The selection of an arterial cannulation site and type of
cannula are important in preventing atheroembolic events,
particularly neurologic complications. The efficacy of var-
ious kinds of arterial cannulation sites has been reported.
Strauch,6 Ogino,2 and their associates reported that SCP
with right axillary artery perfusion had a protective effect
against stroke. When severe atherosclerotic changes are ob-
served in the orifice of the brachiocephalic artery or on the
posterior wall of the ascending aorta,7 perfusion through the
axillary artery should be performed with caution. In most
instances, we selected the ascending aorta as an arterial can-
nulation site after inspection of the epiaortic echographic
scan. Grooters and colleagues8 described the advantages
of arterial perfusion toward the aortic valve. In an experi-
mental study, Fukuda and coworkers9 confirmed that direct-
ing the cannula tip of the Dispersion cannula toward the
aortic root generated slower and less turbulent flow in the
transverse arch of the glass models of both healthy and an-
eurysmal aortic arches. We often experienced that the ath-
erosclerotic change was less frequent just distal to the
sinotubular junction. Accordingly, when we noted the pres-
ence of severe atheroma in the ascending aorta/aortic arch,
we selected the 24F Dispersion cannula and inserted it into
the ascending aorta near the aortic root with perfusion to-
ward the aortic valve. That was a major reason that we sel-
dom selected the right axillary artery perfusion. We could
completely avoid PND in patients with shaggy aorta by
this approach. We believe the approach may have contrib-
uted to the low incidence of neurologic complications that
we observed (PND, 4.4%; TND, 6.6%), although univari-
ate and multivariate analysis failed to identify the use of
a Dispersion cannula as one of the risk reduction factors
for PND or TND. In patients with acute type A dissection,
a femoral artery cannulation was mainly applied. Inasmuch
as the approach is one of the main providers of malperfusion
syndrome, we have recently applied an ascending aorticrdiovascular Surgery c Volume 144, Number 1 141
FIGURE 1. Surgical procedure. A, Aortic arch exposure. B, Aortic cannulation. C, Aortic arch is opened under circulatory arrest at 20C to 23C (tympanic
temperature). D, Antegrade selective cerebral perfusion from inside the aortic arch with trimming of the descending aorta. E, Distal anastomosis under cir-
culatory arrest of the lower part of the body. F, Lower body reperfusion through the branch graft and early rewarming while monitoring of near-infrared
spectroscopy, followed by proximal anastomosis. G, Coronary reperfusion and arch vessel reconstruction, preceded by repair without rewarming of
stenosis/occlusion lesions of carotid or intracranial arteries. H, Discontinuation of cardiopulmonary bypass and completion of total arch replacement.
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Dcannulation10 using a Seldinger method. That was another
reason for scarcity of the right axillary artery perfusion.
Some risk factors for stroke in connection with aortic sur-
gery have been identified.
Aortic diseasse has not been included in the preoperative
risk stratification system such as EuroSCORE but is appar-
ently one of the risk factors for adverse neurologic out-
comes. Our group previously reported that severity of the
aortic arch atheroma grades has been identified as another
risk factor for adverse neurologic outcomes.11 Shaggy aortaFIGURE 2. Number of cases and hospital mortality. Solid line depicts the
number of cases of total arch replacement and bar graphs the overall hos-
pital mortality.
142 The Journal of Thoracic and Cardiovascular Surghas extensive friable and soft atheromatous lesions.4 Amar-
enco and colleagues12 indicated a strong, independent asso-
ciation between atherosclerotic disease of the aortic arch
and the risk of ischemic stroke, particularly with thick pla-
que (4 mm). There were 36 patients with shaggy aorta in
this study. None of 36 patients had PND and 10 (27.8%) of
36 patients had TND. Multivariate analysis demonstrated
that shaggy aorta was a risk factor for TND but not for
PND. We believe that meticulous selection of cannulation
site and type of cannula based on the preoperative and intra-
operative accurate imaging for aortic disease and complete
exclusion of the diseased aorta contributed to avoid PND
even in cases of shaggy aorta.
Contemporary strategies for brain protection are deep hy-
pothermic arrest with or without retrograde cerebral perfu-
sion13 or SCP.14 Although deep hypothermic arrest with or
without retrograde cerebral perfusion does not require an
additional circuit for the brain perfusion, the safety margin
is limited to 40 to 60 minutes.3,15 A prospective
comparative study by one of the coauthors16 confirmed
that SCP significantly reduced the prevalence of temporary
neurologic dysfunction compared with retrograde cerebral
perfusion. Since then, we have consistently selected SCP
under deep hypothermia for brain protection.
The temperature of hypothermic CA during the distal
anastomosis is particularly crucial for protecting vitalery c July 2012
TABLE 2. Risk factors for hospital mortality identified by univariate
and multivariate analysis
Variables
Univariate Multivariate
OR (95% CI)
P
value OR (95% CI)
P
value
Octogenarian 3.09 (1.03-9.23) .04 4.32 (1.19-15.7) .03
Male gender 0.65 (0.21-2.02) .46
Dissection 1.87 (0.63-5.54) .26
Brain malperfusion 30.3 (6.61-138.9) <.0001 21.2 (3.47-130.1) .001
Shaggy aorta 1.34 (0.29-6.24) .71
Emergency/urgent 5.50 (1.68-18.0) .005 2.31 (0.56-9.55) .25
Rupture 1.97 (0.42-9.30) .39
Shock 2.88 (0.33-24.7) .34
Diabetes mellitus 0.58 (0.07-4.56) .60
Old cerebral
infarction
2.61 (0.69-9.91) .16
Coronary artery
disease
2.74 (0.92-8.17) .07
Low LVEF
( 40%)
2.29 (0.27-19.2) .44
COPD 2.27 (0.48-10.8) .30
CKD 2.06 (0.43-9.76) .36
Concurrent
procedure
1.23 (0.42-3.63) .71
CPB time 1.01 (1.00-1.01) .006 1.01 (1.00-1.01) .04
Tympanic
temperature
0.81 (0.57-1.14) .81
Fluid balance
during CPB
1.0 (1.0-1.0) .95
OR, Odds ratio; CI, confidence interval; LVEF, left ventricular ejection fraction;
COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease (creat-
inine  2.0); CPB, cardiopulmonary bypass.
TABLE 3. Risk factors for PND identified by univariate analysis
Variables
Univariate
OR (95% CI) P value
Octogenarian 1.06 (0.29-3.90) .93
Male gender 1.38 (0.38-5.07) .63
Dissection 1.87 (0.63-5.53) .16
Emergency/urgent 2.84 (0.96-8.42) .06
Rupture 3.37 (0.88-12.9) .08
Shock 2.99 (0.34-26.4) .32
Diabetes mellitus 0.58 (0.07-4.56) .58
Old cerebral infarction 1.54 (0.33-7.21) .58
Coronary artery disease 1.41 (0.43-4.62) .57
CKD 2.06 (0.43-9.76) .36
Concurrent procedure 1.23 (0.42-3.63) .71
CPB time 1.004 (1.00-1.01) .25
SCP time 1.01 (1.00-1.02) .11
Tympanic temperature 1.06 (0.79-1.42) .70
Fluid balance during CPB 1.0 (1.0-1.0) .14
Use of 24F Dispersion cannula 0.72 (0.24-2.22) .58
Variables of shaggy aorta, shock status, low left ventricular ejection fraction, andCOPD
were not tested because PND did not occur in cases with the factors. PND, Permanent
neurologic deficit;OR, odds ratio;CI, confidence interval;CKD, chronic kidney disease
(creatinine  2.0); CPB, cardiopulmonary bypass; SCP, selective cerebral perfusion.
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Dorgans. Inasmuch as the primary goal of core cooling is to
achieve a brain temperature compatible with the maximum
suppression of metabolism, the lowest temperature that can
be safely achieved is optimal for brain protection. On the
other hand, deep hypothermia tends to be associated with
coagulopathy, which is to be avoided. Apart from the
deep hypothermic CA with or without retrograde cerebral
perfusion, the optimal temperature in the setting of ante-
grade SCP seems to be between 20C and 28C.1,17,18
Minatoya and associates18 reported that the temperature
during hypothermic CA could be safely increased to 28C
with a high SCP flow rate and that the incidence of neuro-
logic events was not increased with significant reduction
of CA and SCP time. Inasmuch as we have focused more
on the issue of organ protection, we set tympanic tempera-
ture between 20C and 23C, resulting in optimal CA and
SCP times (42.4  27.8 and 97.3  31.4 minutes, respec-
tively). As for the rectal temperature, we aimed it below
30C just before CA. One of our patients whose rectal tem-
perature before CAwas in excess of 30C had entire colon
necrosis, presumably because of calcified stenosis of the
mesenteric artery with poor visceral circulation.The Journal of Thoracic and CaSubsequently, we have always kept rectal temperatures be-
low 30C, without further such complications.
Tominimize CPB time, we start rewarming as soon as the
distal anastomosis is completed, with concurrent antegrade
distal reperfusion to the lower part of the body through the
prosthetic graft branch. Monitoring brain oxygenation dur-
ing rewarming is particularly important because the brain
becomes metabolically hyperactive with progressive oxy-
gen desaturation as a result of the uncoupling of the linear
relationship between brain blood flow and temperature.
NIRS has been used to monitor rSO2 in several clinical set-
tings. Olsson and Thelin19 reported the efficacy on NIRS as
a noninvasive cerebral saturation trend monitor in antegrade
SCP. Baseline values are highly variable between patients,
with mean stable rSO2 levels ranging from 45% to 90%,
making it essential to follow trends in oxygen saturation
changes rather than absolute values. We increased SCP
flow from 10 to 15 mL $ min1 $ m2 to maintain preopera-
tive values of NIRS; however, the total flow was always
maintained below 1200 mL/min to avoid brain edema.
The use of CPB is invariably associated with fluid over-
load followed by fluid extravasation from the circulation
to the interstitial space, which occasionally leads to organ
dysfunction, particularly in the lungs. The main causes of
CPB-related edema are the occurrence of systemic inflam-
matory responses and hemodilution. Strategies to reduce
the inflammatory response have chiefly focused on the phar-
macologic approaches. Steroids are often used as anti-
inflammatory agents and may lessen complement activation
by causing in vitro inhibition of C3 and C5 convertase.20
However, there are few reports that demonstrate clinicallyrdiovascular Surgery c Volume 144, Number 1 143
TABLE 4. Risk factors for TND identified by univariate and
multivariate analysis
Variables
Univariate Multivariate
OR (95% CI)
P
value OR (95% CI)
P
value
Octogenarian 1.22 (0.43-3.47) .70
Male gender 2.33 (0.67-8.12) .18
Dissection 0.11 (0.02-0.84) .04 0.48 (0.05-5.00) .54
Shaggy aorta 9.58 (3.72-24.7) <.0001 3.73 (1.26-11.1) .018
Emergency/urgent 0.20 (0.05-0.87) .04 0.73 (0.13-4.09) .72
Rupture 0.55 (0.07-4.27) .57
Diabetes mellitus 0.80 (0.18-3.57) .77
Old cerebral
infarction
1.56 (0.43-5.61) .50
Coronary artery
disease
4.31 (1.75-10.6) .002 2.36 (0.45-12.3) .31
Low LVEF (40%) 9.85 (2.63-37.0) .0007 4.90 (1.00-23.9) .05
COPD 4.90 (1.61-14.9) .05 2.04 (0.54-7.75) .30
CKD 3.13 (0.96-10.1) .05
Concurrent
procedure
2.83 (1.14-7.05) .03 0.80 (0.15-4.20) .79
CPB time 1.00 (1.00-1.01) .27
SCP time 0.99 (0.98-1.01) .45
Tympanic
temperature
0.89 (0.68-1.16) .77
Use of 24F
Dispersion
cannula
6.29 (0.24-2.22) .001 2.49 (0.71-8.76) .16
Avariable of shock status was not tested because permanent neurologic deficit did not
occur in cases associated with shock. TND, Transient neurologic deficit; OR, odds
ratio; CI, confidence interval; LVEF, left ventricular ejection fraction; CPD, chronic
obstructive pulmonary disease;CKD, chronic kidney disease (creatinine 2.0);CPB,
cardiopulmonary bypass; SCP, selective cerebral perfusion.
FIGURE 3. Survival curve. Survival at 3 and 5 years after surgery was
82.4%  2.5% and 78.5%  3.1%, respectively.
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Dsignificant in vivo effects of these agents.21 Neutrophil ac-
tivation and sequestration, by facilitating secretion of neu-
trophil elastase, may also cause pulmonary dysfunction.
Sivelestat sodium hydrate is a synthetic low-molecular-
weight specific neutrophil elastase inhibitor.22 We have
used 100 mg of sivelestat into the pump circuit at theTABLE 5. Additional postoperative complications
Variables No (%)
Paraplegia 3 (0.9)
Temporary 1 (0.3)
Permanent 2 (0.6)
Paraparesis 1 (0.3)
Temporary 1 (0.3)
Mediastinitis 7 (2.4)
Mean mechanical ventilation time (h) 26.5  46.4
Prolonged ventilation (48 h) 53 (16.5)
Prolonged ventilation after 2006 25 (12.6)*
Renal failure 10 (3.1)
Gastrointestinal tract 8 (2.5)
Bleeding 6 (1.9)
Necrosis 2 (0.6)
*P ¼ .02 versus before 2006.
144 The Journal of Thoracic and Cardiovascular Surginitiation of CPB with attenuation of postoperative pulmo-
nary dysfunction as assessed from respiratory and oxygen-
ation indices, and with earlier tracheal extubation.5 As
regards hemodilution, a highly positive fluid balance during
CPB is associated with adverse outcomes such as increases
in the requirement for blood transfusion and in-hospital
mortality.23 Inasmuch as lungs are particularly susceptible
to fluid overload, pulmonary dysfunction may occur and re-
sult in prolonged postoperative mechanical ventilatory sup-
port.24 Therefore, maintaining fluid balance as close to
physiologic as possible is crucial. Oliver and associates25
reported that control of fluid balance by hemofiltration fa-
cilitated earlier tracheal extubation after normothermic
CPB, although no mechanism was elucidated to account
for this result. The literature reported that hemofiltration
during CPB resulted in 27 mL/kg26 of ultrafiltrate with
1.18  1.99 L of fluid balance. Beginning in 2006, weFIGURE 4. Freedom from aorta-related death. Freedom from aorta-
related death 3 and 5 years after surgery was 97.9%  1.1% and
97.9%  1.1%, respectively.
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Dalso sought to achieve a 1-L fluid balance and noted a signif-
icant decrease from 1311.0  1463.8 mL before 2006 to
712.5  1551.6 mL (P ¼ .001) afterward, as well a reduc-
tion in the percentage of patients requiring prolonged ven-
tilation from 22.8% to 12.6% (P ¼ .02). Inasmuch as
optimal fluid balance during CPB under deep hypothermia
remains unknown, further investigation of this issue will be
required.
Previous reports have demonstrated improved outcomes
both inmortality and in the incidence of permanent stroke re-
sulting from various kinds ofmultimodal approaches.1,2,17,27
Recent reports have indicated that results of conventional
aortic arch surgery even in octogenarians is improving.28
In the current study, overall hospital mortality was satisfac-
tory but that in octogenarian was 9.1% (6/66) and the status
was identified as a risk factor for hospital mortality (OR,
4.32; P ¼ .03). However, our evolving procedures provided
the drastic improvement in octogenarians with a significant
reduction in hospital mortality over the 5 years (14.2% be-
fore 2006 vs 2.6% after 2006, P ¼ .03). We can expect fur-
ther advancements in the era of the aged society. Although
the underlying specific reasons for the recent improvement
in outcomes fromuse of standardized approaches remain un-
clear, there is evidence at our institute that strict water bal-
ance during CPB may be one of the important factors.
Finally, the long-term outcome was satisfactory, particu-
larly in the freedom from aorta-related death, which con-
firmed thatTARwas evolving treatmentwith better durability.
LIMITATIONS
This is a retrospective study from a single center. Al-
though the favorable outcomes we observed appeared to
be the result of our standardized surgical approach for
TAR, further prospective studies are required to validate
this process and identify those factors that contribute most
strongly to this outcome.
CONCLUSIONS
Our approach for TAR has contributed to low hospital
mortality and morbidities and with favorable long-term
outcome.
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